rs708905
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006732.3(FOSB):c.*1202G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 151,988 control chromosomes in the GnomAD database, including 1,832 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1831 hom., cov: 30)
Exomes 𝑓: 0.11 ( 1 hom. )
Consequence
FOSB
NM_006732.3 3_prime_UTR
NM_006732.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.13
Publications
11 publications found
Genes affected
FOSB (HGNC:3797): (FosB proto-oncogene, AP-1 transcription factor subunit) The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ERCC1 (HGNC:3433): (ERCC excision repair 1, endonuclease non-catalytic subunit) The product of this gene functions in the nucleotide excision repair pathway, and is required for the repair of DNA lesions such as those induced by UV light or formed by electrophilic compounds including cisplatin. The encoded protein forms a heterodimer with the XPF endonuclease (also known as ERCC4), and the heterodimeric endonuclease catalyzes the 5' incision in the process of excising the DNA lesion. The heterodimeric endonuclease is also involved in recombinational DNA repair and in the repair of inter-strand crosslinks. Mutations in this gene result in cerebrooculofacioskeletal syndrome, and polymorphisms that alter expression of this gene may play a role in carcinogenesis. Multiple transcript variants encoding different isoforms have been found for this gene. The last exon of this gene overlaps with the CD3e molecule, epsilon associated protein gene on the opposite strand. [provided by RefSeq, Oct 2009]
ERCC1 Gene-Disease associations (from GenCC):
- cerebrooculofacioskeletal syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Cockayne syndrome type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- COFS syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.224 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FOSB | NM_006732.3 | c.*1202G>C | 3_prime_UTR_variant | Exon 4 of 4 | ENST00000353609.8 | NP_006723.2 | ||
| FOSB | NM_001114171.2 | c.*1202G>C | 3_prime_UTR_variant | Exon 3 of 3 | NP_001107643.1 | |||
| FOSB | NM_001411069.1 | c.*1365G>C | 3_prime_UTR_variant | Exon 5 of 5 | NP_001397998.1 | |||
| FOSB | XM_047438550.1 | c.*1365G>C | 3_prime_UTR_variant | Exon 4 of 4 | XP_047294506.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.145 AC: 22001AN: 151760Hom.: 1834 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
22001
AN:
151760
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.109 AC: 12AN: 110Hom.: 1 Cov.: 0 AF XY: 0.125 AC XY: 9AN XY: 72 show subpopulations
GnomAD4 exome
AF:
AC:
12
AN:
110
Hom.:
Cov.:
0
AF XY:
AC XY:
9
AN XY:
72
show subpopulations
African (AFR)
AF:
AC:
0
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
0
AN:
2
European-Finnish (FIN)
AF:
AC:
10
AN:
98
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
1
AN:
4
Other (OTH)
AF:
AC:
0
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.145 AC: 21999AN: 151878Hom.: 1831 Cov.: 30 AF XY: 0.140 AC XY: 10389AN XY: 74228 show subpopulations
GnomAD4 genome
AF:
AC:
21999
AN:
151878
Hom.:
Cov.:
30
AF XY:
AC XY:
10389
AN XY:
74228
show subpopulations
African (AFR)
AF:
AC:
9440
AN:
41390
American (AMR)
AF:
AC:
1450
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
389
AN:
3468
East Asian (EAS)
AF:
AC:
258
AN:
5138
South Asian (SAS)
AF:
AC:
823
AN:
4796
European-Finnish (FIN)
AF:
AC:
740
AN:
10584
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8483
AN:
67932
Other (OTH)
AF:
AC:
282
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
915
1829
2744
3658
4573
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
409
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.